Arctic Bioscience Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Christer Valderhaug

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	0.02%
Permanencia media de la dirección	5.8yrs
Promedio de permanencia en la Junta Directiva	4.8yrs

Actualizaciones recientes de la dirección

Recent updates

We're Hopeful That Arctic Bioscience (OB:ABS) Will Use Its Cash Wisely

Jul 08

Here's Why We're Not Too Worried About Arctic Bioscience's (OB:ABS) Cash Burn Situation

Apr 09

CEO

Christer Valderhaug (52 yo)

no data

Permanencia

Mr. Christer L. Valderhaug serves as Chief Executive Officer at Arctic Bioscience AS. He serves as Senior Advisor at Converto Holding As (formerly known as Converto AS) since November 2016. He came from th...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Harald Nordal	Co-Founder & Chairman	8.8yrs	sin datos	sin datos
Christer Valderhaug	Chief Executive Officer	no data	sin datos	0.016% NOK 41.6k
Hogne Hallaraker	Founder & Chief Scientific Officer	6.3yrs	sin datos	1.77% NOK 4.7m
Jone Slinning	Chief Financial Officer	2.3yrs	sin datos	0.052% NOK 137.3k
Per Sæbo	Chief Operating Officer	12yrs	sin datos	0.090% NOK 238.6k
Daniele Mancinelli	Chief Technical Officer	12yrs	sin datos	0.027% NOK 71.1k
Steffen Eidal	Senior Vice President of Sales & Marketing	2.3yrs	sin datos	sin datos
Yuming Feng	Executive Vice President of Global Business Development	5.8yrs	sin datos	sin datos
Runhild Gammelsæter	Global Medical Director	4.9yrs	sin datos	0.098% NOK 257.6k

5.8yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de ABS es experimentado (5.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Harald Nordal	Co-Founder & Chairman	8.8yrs	sin datos	sin datos
Jostein Dalland	Independent Board Member	4.3yrs	sin datos	sin datos
Asbjorn Solevagseide	Board Member	5.3yrs	sin datos	sin datos
Jan Vartdal	Board Member	8.8yrs	sin datos	4.1% NOK 10.8m
Per Eggesbo	Board Member	8.5yrs	sin datos	sin datos
Hu Cao	Board Member	3.4yrs	sin datos	sin datos
Tore Andreas Tonseth	Board Member	3.5yrs	sin datos	sin datos
Marita Holstad	Director	3.5yrs	sin datos	sin datos

4.8yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de ABS se considera experimentada (4.7 años de antigüedad promedio).

Arctic Bioscience Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Global Medical Director recently bought kr160k worth of stock

Chief Executive Officer recently bought kr299k worth of stock

Less than half of directors are independent

Global Medical Director recently bought kr101k worth of stock

Less than half of directors are independent

Board Member recently bought kr220k worth of stock

Recent updates

Arctic Bioscience Announces New Positive Data Showing Anti-Inflammatory Effects of Phospholipid Esters from Herring Roe in Immune Cells

Full year 2023 earnings: EPS and revenues miss analyst expectations

Full year 2023 earnings released

Arctic Bioscience AS to Report Q4, 2023 Results on Mar 01, 2024

Arctic Bioscience AS to Report Q4, 2023 Results on Mar 01, 2024

New major risk - Revenue and earnings growth

New major risk - Share price stability

Arctic Bioscience Announces Recruitment Completed in the Phase IIb HeROPA Clinical Trial

Arctic Bioscience AS to Report Fiscal Year 2023 Results on Apr 09, 2024

Arctic Bioscience Announces More Than 75% Recruitment in the Phase IIb HeROPA Clinical Trial

Arctic Bioscience AS Provides Revenue Guidance for the Year 2023

New minor risk - Financial data availability

Arctic Bioscience AS Provides Earnings Guidance for the Year 2023

Consensus EPS estimates upgraded to kr1.74 loss, revenue downgraded

Arctic Bioscience as Announces Operational Update - Heropa Clinical Trial Approved in All 5 Countries and Ongoing

Full year 2022 earnings: Revenues miss analyst expectations

Global Medical Director recently bought kr160k worth of stock

Chief Executive Officer recently bought kr299k worth of stock

Arctic Bioscience AS (OB:ABS) acquired Arctic Algae As from Ronja Capital II AS for enterprise value NOK 16.3 million.

Arctic Bioscience Announces First Patient Included in HRO350 Phase IIb Clinical Trial in the UK

Arctic Bioscience Announces Clinical Trial Application for HRO350 Phase IIb Approves in UK

Arctic Bioscience AS to Report Fiscal Year 2022 Results on Mar 29, 2023

Price target decreased to kr15.00

Less than half of directors are independent

Arctic Bioscience as Maintains Earnings Guidance for the Year 2022

Arctic Bioscience Submits Clinical Trial Application for Hro350 Phase IIb

Arctic Bioscience AS Announces Update on Clinical Trial Application for HRO350 Phase IIb

Consensus forecasts updated

Arctic Bioscience as Provides Revenue Guidance for the Year 2022

We're Hopeful That Arctic Bioscience (OB:ABS) Will Use Its Cash Wisely

Global Medical Director recently bought kr101k worth of stock

Less than half of directors are independent

Board Member recently bought kr220k worth of stock

Here's Why We're Not Too Worried About Arctic Bioscience's (OB:ABS) Cash Burn Situation

Full year 2021 earnings: Revenues miss analyst expectations

Arctic Bioscience Provides Earnings Guidance for the Fiscal Year 2022

Arctic Bioscience Announces Termination Danielle Glenn as CFO

Arctic Bioscience AS Provides Earnings Guidance for the Year 2021

Arctic Bioscience Receives Grant from the Research Council of Norway for Its Pharmaceutical Development

Arctic Bioscience Provides Financial Guidance for the Fiscal Year 2021

Arctic Bioscience Signs 3-Year Agreement Worth 75 Million NOK with Smerud Medical Research International to Conduct Clinical Study on Psoriasis

Board Member recently bought kr498k worth of stock

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad